Chad Duncan (Chief Financial Officer) and Karen LaRochelle (SVP, Global Business Development and Strategy) are listed as the contacts to pitch at Merz Therapeutics.

Across the known portfolio, 2 co-investors appear alongside Merz Therapeutics, including Israel Biotech Fund and Laborie.

Frequently asked questions

What is Merz Therapeutics?

Merz Therapeutics is a corporate venture arm based in Frankfurt am Main, Germany, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Merz Therapeutics invest in?

Listed sectors include Healthcare; listed focus areas include Healthcare Operations, MedTech, Medical Devices and Neurotoxins. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Merz Therapeutics invest at?

Merz Therapeutics is listed for Seed rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Merz Therapeutics?

Both people on file at Merz Therapeutics are listed as contacts for the firm, each with their own profile page.

How do I contact Merz Therapeutics?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal